NasdaqGS - Nasdaq Real Time Price USD

bluebird bio, Inc. (BLUE)

Compare
6.34 -1.26 (-16.58%)
At close: December 13 at 4:00:02 PM EST
6.49 +0.15 (+2.37%)
After hours: 7:58:52 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
53,120.00
29,497.00
3,597.00
3,662.00
--
Cost of Revenue
78,783.00
33,527.00
10,077.00
38,857.00
--
Gross Profit
-25,663.00
-4,030.00
-6,480.00
-35,195.00
--
Operating Expense
292,813.00
240,232.00
238,765.00
529,915.00
559,259.00
Operating Income
-318,476.00
-244,262.00
-245,245.00
-565,110.00
-559,259.00
Net Non Operating Interest Income Expense
-11,933.00
-6,484.00
-5,290.00
879.00
5,770.00
Other Income Expense
37,501.00
38,707.00
20,310.00
1,851.00
-6,881.00
Pretax Income
-292,908.00
-212,039.00
-230,225.00
-562,380.00
-560,370.00
Tax Provision
-83.00
-126.00
117.00
258.00
686.00
Net Income Common Stockholders
-292,825.00
-211,913.00
-230,342.00
-819,378.00
-618,695.00
Diluted NI Available to Com Stockholders
-292,825.00
-211,913.00
-230,342.00
-819,378.00
-618,695.00
Basic EPS
-1.80
-1.93
-3.39
-11.89
-9.95
Diluted EPS
-1.80
-1.93
-3.39
-11.89
-9.95
Basic Average Shares
174,823.00
109,825.00
78,585.00
68,190.00
62,178.00
Diluted Average Shares
174,823.00
109,825.00
78,585.00
68,190.00
62,178.00
Total Operating Income as Reported
-321,287.00
-244,262.00
-250,185.00
-590,911.00
-559,259.00
Total Expenses
371,596.00
273,759.00
248,842.00
568,772.00
559,259.00
Net Income from Continuing & Discontinued Operation
-292,825.00
-211,913.00
-230,342.00
-819,378.00
-618,695.00
Normalized Income
-290,014.80
-211,913.00
-226,439.40
-543,803.27
-561,056.00
Interest Income
8,964.00
9,869.00
1,032.00
879.00
5,770.00
Interest Expense
20,897.00
16,353.00
6,322.00
--
--
Net Interest Income
-11,933.00
-6,484.00
-5,290.00
879.00
5,770.00
EBIT
-272,011.00
-195,686.00
-223,903.00
-565,110.00
-559,259.00
EBITDA
-215,807.00
-167,161.00
-215,559.00
-545,461.00
-539,903.00
Reconciled Cost of Revenue
78,783.00
33,527.00
10,077.00
38,857.00
--
Reconciled Depreciation
56,204.00
28,525.00
8,344.00
19,649.00
19,356.00
Net Income from Continuing Operation Net Minority Interest
-292,825.00
-211,913.00
-230,342.00
-562,638.00
-561,056.00
Total Unusual Items Excluding Goodwill
-2,811.00
--
-4,940.00
-25,801.00
--
Total Unusual Items
-2,811.00
--
-4,940.00
-25,801.00
--
Normalized EBITDA
-212,996.00
-167,161.00
-210,619.00
-519,660.00
-539,903.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-0.80
--
-1,037.40
-6,966.27
--
12/31/2020 - 6/19/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EDIT Editas Medicine, Inc.
1.4400
-23.81%
 
TSVT 2seventy bio, Inc.
3.2700
-2.10%
 
IBRX ImmunityBio, Inc.
2.8700
-5.59%
 
QURE uniQure N.V.
15.40
+2.26%
 
LXRX Lexicon Pharmaceuticals, Inc.
0.8103
-1.45%
 
CRSP CRISPR Therapeutics AG
43.78
-3.57%
 
CMRX Chimerix, Inc.
2.9500
+0.34%
 
NTLA Intellia Therapeutics, Inc.
12.90
-4.87%
 
BEAM Beam Therapeutics Inc.
27.93
-0.46%
 
MGX Metagenomi, Inc.
3.2400
-16.06%